Insights

US Expansion Milford expansion solidifies the United States as a core hub for commercial manufacturing and faster tech transfer for US clients, signaling growing capacity to support late-stage development and commercial programs.

Regulatory Leadership Proven regulatory leadership with strong quality systems, evidenced by substantial contribution to FDA-approved biologics, creates an opportunity to offer end-to-end CMC regulatory support, dossier preparation, and lifecycle management services.

Sustainability Focus Sustainability initiatives, including joining the UN Global Compact, open doors for partnerships on green manufacturing, energy efficiency, and ESG data services that resonate with biopharma clients' sustainability goals.

Digital Advantage Advanced digital infrastructure with Azure Data Factory, SCADA, LabVantage, SAP, and collaboration tools enables data-driven development and scalable manufacturing; ideal for offering data integration, MES/LIMS optimization, and predictive analytics to accelerate programs.

US Leadership Strategic US leadership expansion, with a new US head of business development and fresh executive appointments, highlights a targeted approach to US partnerships, co-development deals, and regional supply chain advantages.

Rentschler Biopharma Tech Stack

Rentschler Biopharma uses 8 technology products and services including Azure Synapse Analytics, TYPO3, SCADA, and more. Explore Rentschler Biopharma's tech stack below.

  • Azure Synapse Analytics
    Big Data Processing
  • TYPO3
    Content Management System
  • SCADA
    Control Systems
  • SAP R/3
    Enterprise Resource Planning
  • LabVantage
    Health Platform
  • Office 365
    Office Suites
  • Microsoft SharePoint Online
    Team Collaboration
  • Atlassian Confluence
    Wikis

Media & News

Rentschler Biopharma's Email Address Formats

Rentschler Biopharma uses at least 2 format(s):
Rentschler Biopharma Email FormatsExamplePercentage
First.Last@rentschler-biopharma.comJohn.Doe@rentschler-biopharma.com
99%
Last@rentschler-biopharma.comDoe@rentschler-biopharma.com
1%
First.Last@rentschler.deJohn.Doe@rentschler.de
99%
Last@rentschler.deDoe@rentschler.de
1%

Frequently Asked Questions

What is Rentschler Biopharma's official website and social media links?

Minus sign iconPlus sign icon
Rentschler Biopharma's official website is rentschler-biopharma.com and has social profiles on LinkedIn.

What is Rentschler Biopharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Rentschler Biopharma's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Rentschler Biopharma have currently?

Minus sign iconPlus sign icon
As of July 2026, Rentschler Biopharma has approximately 901 employees across 4 continents, including EuropeNorth AmericaAfrica. Key team members include Cfo: G. V. V. D.Cbo: F. T.Chief Operating Officer: C. B.. Explore Rentschler Biopharma's employee directory with LeadIQ.

What industry does Rentschler Biopharma belong to?

Minus sign iconPlus sign icon
Rentschler Biopharma operates in the Biotechnology Research industry.

What technology does Rentschler Biopharma use?

Minus sign iconPlus sign icon
Rentschler Biopharma's tech stack includes Azure Synapse AnalyticsTYPO3SCADASAP R/3LabVantageOffice 365Microsoft SharePoint OnlineAtlassian Confluence.

What is Rentschler Biopharma's email format?

Minus sign iconPlus sign icon
Rentschler Biopharma's email format typically follows the pattern of First.Last@rentschler-biopharma.com. Find more Rentschler Biopharma email formats with LeadIQ.

How much funding has Rentschler Biopharma raised to date?

Minus sign iconPlus sign icon
As of July 2026, Rentschler Biopharma has raised $1.6M in funding. The last funding round occurred on May 18, 2016.

When was Rentschler Biopharma founded?

Minus sign iconPlus sign icon
Rentschler Biopharma was founded in 1927.
Rentschler Biopharma logo

Rentschler Biopharma

Biotechnology ResearchBaden-Württemberg, Germany501-1000 Employees

Rentschler Biopharma is a biotechnology research-focused contract development and manufacturing organization (CDMO) that serves exclusively client projects. It provides process development and manufacturing of biopharmaceuticals, along with consulting, project management, and regulatory support. The company emphasizes a high-quality management system, operational excellence, and advanced technologies to ensure product quality and productivity across development and manufacturing. It is a family-owned company headquartered in Laupheim, Germany, with operations in Milford, Massachusetts, USA. The organization lists a workforce of 501-1000 employees. In 2023, it contributed to nearly 25% of all FDA-approved biologics, and in 2024 it joined the United Nations Global Compact, reflecting a sustainability focus.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1927
Employees
501-1000

Section iconFunding & Financials

  • $1.6M

    Rentschler Biopharma has raised a total of $1.6M of funding over 1 rounds. Their latest funding round was raised on May 18, 2016as a series_a.

  • $100M$250M

    Rentschler Biopharma's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $1.6M

    Rentschler Biopharma has raised a total of $1.6M of funding over 1 rounds. Their latest funding round was raised on May 18, 2016as a series_a.

  • $100M$250M

    Rentschler Biopharma's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.